Aeterna Zentaris: Posters to be Presented on Phase 1 and Phase 2 Trials with AEZS-108 in Prostate and Breast Cancer at Upcomi... Aeterna Zentaris... ...
http://in.advfn.com/p.php?pid=nmona&article=57701276-- First quarter 2013 revenue rose 23% to EUR 5.9 million (USD 7.8 million) -- Continuing US investments in both FDA regulatory process and US... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=310431Four Scientific Sessions Highlighted HIFU for Treatment of Prostate Cancer HIFU Featured in Plenary Lecture and Two Moderated Posters at... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=310163Regional Experience Substantiates Positive Global Data for novoGI(TM) ColonRing ATLANTA, May 13, 2013 (GLOBE NEWSWIRE) -- novoGI Inc. today... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=309955Aeterna Zentaris Inc. (AEZ) Quote : 1.84 0.0 (0.00%) @ 1:40AM Aeterna Zentaris (TSX:AEZ) Intraday Stock Chart Today : Wednesday 8 May 2013 All... ...
http://in.advfn.com/p.php?pid=nmona&article=57462899